Methenamine Mandelate Delayed-Release Tablets
» Methenamine Mandelate Delayed-Release Tablets contain not less than 95.0 percent and not more than 105.0 percent of the labeled amount of methenamine mandelate (C6H12N4·C8H8O3).
Packaging and storage— Preserve in well-closed containers.
USP Reference standards 11
USP Methenamine Mandelate RS Click to View Structure
Disintegration 701: 2 hours and 30 minutes, determined as directed under Delayed-release (enteric coated) Tablets.
Other requirements— Delayed-release Tablets respond to the Identification test and meet the requirements for Uniformity of dosage units and Assay under Methenamine Mandelate Tablets.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Leonel M. Santos, Ph.D.
Senior Scientific Liaison
(SM12010) Monographs - Small Molecules 1
Reference Standards RS Technical Services
701 Margareth R.C. Marques, Ph.D.
Senior Scientific Liaison
(GCDF2010) General Chapters - Dosage Forms
USP35–NF30 Page 3850